<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04338633</url>
  </required_header>
  <id_info>
    <org_study_id>314</org_study_id>
    <nct_id>NCT04338633</nct_id>
  </id_info>
  <brief_title>Post-operative Pain Reduction</brief_title>
  <official_title>Post-operative Pain Reduction After Application of Three Intracanal Medicament Within Necrotic Root Canals and Pulp</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recruited patients with necrotic pulp after application of conventional calcium hydroxide
      paste are assigned to group, Calcium hydroxide nanoparticle group and Combined Calcium
      hydroxide with silver nanoparticle group and record postoperative pain afterwards.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator will recruit patients who are found eligible to the criteria, conventional
      calcium hydroxide paste , Calcium hydroxide nanoparticle and Combined Calcium hydroxide with
      silver nanoparticle . After 48 hours, patients will be randomly assigned to removal of
      intracanal medication

      After the visit, patients will be asked to record post operative pain by Numerical Rating
      Scale)in a given sheet
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>double</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change in post operative pain (Visual Analogue Scale)</measure>
    <time_frame>Intrappointment at 4,24,48,72 and 96 hours ]</time_frame>
    <description>Numerical (0-10)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Effects of the Elements</condition>
  <arm_group>
    <arm_group_label>Conventional calcium hydroxide paste</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of Conventional calcium hydroxide paste</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium hydroxide nanoparticle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of Calcium hydroxide nanoparticle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined Calcium hydroxide with silver nanoparticle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of Combined Calcium hydroxide with silver nanoparticle</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Conventional calcium hydroxide paste</intervention_name>
    <description>Conventional calcium hydroxide paste (Ultracal) will be removed in second visit.</description>
    <arm_group_label>Conventional calcium hydroxide paste</arm_group_label>
    <other_name>Ultracal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium hydroxide nanoparticle</intervention_name>
    <description>Calcium hydroxide nanoparticle. manufactured in NanoTech. institute, will be removed in second visit.</description>
    <arm_group_label>Calcium hydroxide nanoparticle</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combined Calcium hydroxide with silver nanoparticle</intervention_name>
    <description>Combined Calcium hydroxide with silver nanoparticle will be removed in second visit.</description>
    <arm_group_label>Combined Calcium hydroxide with silver nanoparticle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Medically free patients.

               -  Patient's age between 25-50 years.

               -  Sex includes both male and female.

               -  Radiographic evidence of a periapical radiolucent lesion associated with tooth.

               -  Necrotic pulp as indicated by thermal pulp testing.

               -  No history of previous endodontic treatment of the tooth.

        Exclusion Criteria:

          -  • Teeth with unfavorable conditions for rubber-dam application.

               -  Teeth with acute periapical abscesses swelling.

               -  Medically compromised patients.

               -  Immature teeth with open apices.

               -  Multi rooted teeth.

               -  Pregnant women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magdy Mohamed Aly, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Dean of Faculty</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Salah Hegazi</last_name>
    <phone>+201224014179</phone>
    <email>mshegazi2006@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reham Hassan, Assoc Prof</last_name>
    <phone>+201001542529</phone>
    <email>reham-hassan@live.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Dentistry, Minia University</name>
      <address>
        <city>Minya</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reham Hassan, Assoc Prof</last_name>
      <phone>+201001542529</phone>
      <email>reham-hassan@live.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Singh RD, Khatter R, Bal RK, Bal CS. Intracanal medications versus placebo in reducing postoperative endodontic pain--a double-blind randomized clinical trial. Braz Dent J. 2013;24(1):25-9.</citation>
    <PMID>23657409</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2020</study_first_posted>
  <last_update_submitted>April 6, 2020</last_update_submitted>
  <last_update_submitted_qc>April 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Mohamed Salah Mohamed Fahmy</investigator_full_name>
    <investigator_title>PHD Candidate - Endodontic Department- Faculty of Dentistry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

